T1	Participants 83 130	children receiving combined cancer chemotherapy
T2	Participants 466 540	children receiving highly emetogenic chemotherapy for various malignancies
T3	Participants 553 593	51 children (mean age: 7.7 +/- 4.8 year)
T4	Participants 2247 2296	children receiving highly emetogenic chemotherapy
